Clinical Recommendations for Perioperative Immunotherapy-induced Adverse Events in Patients with Non-small Cell Lung Cancer

Clinical Recommendations for Perioperative Immunotherapy-induced Adverse Events in Patients with Non-small Cell Lung Cancer

Show other versions (1)

Background and objective Perioperative treatment has become an increasingly important aspect of the management of patients with non-small cell lung cancer (NSCLC). Small-scale clinical studies performed in recent years have shown improvements in the major pathological remission rate after neoadjuvan...

Full description

Bibliographic Details
Main Authors: Jun NI, Miao HUANG, Li ZHANG, Nan WU, Chunxue BAI, Liang’an CHEN, Jun LIANG, Qian LIU, Jie WANG, Yilong WU, Fengchun ZHANG, Shuyang ZHANG, Chun CHEN, Jun CHEN, Wentao FANG, Shugeng GAO, Jian HU, Tao JIANG, Shanqing LI, Hecheng LI, Yongde LIAO, Yang LIU, Deruo LIU, Hongxu LIU, Jianyang LIU, Lunxu LIU, Mengzhao WANG, Changli WANG, Fan YANG, Yue YANG, Lanjun ZHANG, Xiuyi ZHI, Wenzhao ZHONG, Yuzhou GUAN, Xiaoxiao GUO, Chunxia HE, Shaolei LI, Yue LI, Naixin LIANG, Fangliang LU, Chao LV, Wei LV, Xiaoyan SI, Fengwei TAN, Hanping WANG, Jiangshan WANG, Shi YAN, Huaxia YANG, Huijuan ZHU, Junling ZHUANG, Minglei ZHUO
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2021-03-01
Series:Chinese Journal of Lung Cancer
Subjects:
lung neoplasms
perioperative immunotherapy
immune checkpoint inhibitor related adverse events
clinical recommendation
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.06

Similar Items

Similar Items